
11 - 50 employees
πΌ Consulting
π Manufacturing
𧬠Biotechnology
π° $12M Seed Round on 2023-01
Consulting β’ Manufacturing β’ Biotechnology
ImmuneBridge is developing allogeneic immunotherapies for cancer, leveraging its proprietary technology to expand cord blood-derived immune stem cells significantly. This innovative approach aims to provide a novel, scalable source of immunotherapies, particularly focusing on natural killer (NK) cells to address hematological malignancies while planning to tackle solid tumors in the future. Their platform reduces costs and accelerates discovery by using cord blood instead of iPSCs, allowing for efficient matching of HLA types and rapid iterations of therapeutic cell sources.
π October 16
Where this job comes from
Posted on ImmuneBridge's careers page β, not through a job board
First seen by Remote Rocketship October 16
Still open on ImmuneBridge's site. Checked 39 minutes ago.

11 - 50 employees
πΌ Consulting
π Manufacturing
𧬠Biotechnology
π° $12M Seed Round on 2023-01
Consulting β’ Manufacturing β’ Biotechnology
ImmuneBridge is developing allogeneic immunotherapies for cancer, leveraging its proprietary technology to expand cord blood-derived immune stem cells significantly. This innovative approach aims to provide a novel, scalable source of immunotherapies, particularly focusing on natural killer (NK) cells to address hematological malignancies while planning to tackle solid tumors in the future. Their platform reduces costs and accelerates discovery by using cord blood instead of iPSCs, allowing for efficient matching of HLA types and rapid iterations of therapeutic cell sources.
β’ Own CMC for the lead trispecific T-cell engager program from discovery handoff through IND β’ Build and manage the integrated CMC plan from development candidate nomination to first-in-human β’ Run a competitive CDMO selection RFP across US, European, and Chinese CDMOs β’ Negotiate and manage the selected CDMO across cell line, process, analytical, technology transfer, GMP manufacturing, and stability activities β’ Own outsourced manufacturing quality, including quality agreements, batch records, deviations, OOS handling, specifications, and GMP material release/disposition β’ Own the CMC budget and forecast against the cash plan β’ Own analytical and release strategy, including the cell-based potency assay β’ Secure GLP toxicology material and manage clinical supply, labeling, packaging, comparator sourcing, and shipment to trial sites β’ Author and QC Module 3 and build CMC content for the pre-IND briefing package β’ Participate in agency meetings β’ Identify format-driven CMC risks involving chain pairing, product-related species, and purification strategy β’ Report on an interim basis to the Head of Research pending hire of the Chief Scientific Officer
β’ PhD in a relevant discipline, or a BS or MS with at least 12 years in biologics CMC β’ At least 1 biologic taken from development candidate to IND with the CMC package filed, ideally a bispecific or multispecific rather than a monoclonal β’ Direct experience selecting and managing CDMOs, including writing the RFP and reading the quotes critically β’ Quality fluency sufficient to negotiate a quality agreement and to make a release decision on outsourced GMP material β’ Module 3 authoring or QC, and enough regulatory fluency to defend the CMC section in an agency meeting β’ Comfort working with CDMOs in China alongside US and European options, and a clear view on the trade-offs β’ Judgment on when to push a timeline and when to refuse one β’ Experience in biologics CMC β’ Role starts under a consulting agreement; it is not a full-time hire on day 1
β’ Consulting agreement to start, with a monthly hours cap β’ Remote work is permitted β’ Intended conversion to a full-time permanent position as further programs reach the same point
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π October 14
Director of IT leading infrastructure, cybersecurity, compliance, and technology strategy for Uprise Health. Driving scalable systems and operational efficiency across mental and behavioral healthcare services.
πΊπΈ United States β Remote
π΅ $165k - $175k / year
β³ Contract/Temporary
π΄ Lead
π Director
π August 11
Senior testing, inspection, and certification operators advising Fireclay Partnersβ M&A and buy-side engagements. Providing sector intelligence, operational diligence, networks, and transaction support on a flexible per-deal basis.
π July 28
Coaching senior leaders in policy roles through 1:1 coaching sessions at Mento. Engaging with technology companies and contributing to shaping effective policy frameworks.
π June 27
Director of Technology consulting role at Fireclay Partners, providing expert operational insights in technology services and software sectors. Engaging in specific deals with private equity firms based on domain expertise.
π June 27
Consultant advising private equity sponsors on industrial manufacturing operations. Engaging for specific deals leveraging deep domain expertise in various subsectors.